| 2022 | Charsire is established for 20 years. The epidemic is severe, so Charsire launched a caring medical staff activity and set out gratitude care packages. |
| 2021 | Sports care activity for Kaohsiung Municipal Fushan Elementary School table tennis team |
| 2021 | Sports care activity for eSports team of Cheng Shiu University |
| 2021 | Acquired EU BSI medical device manufacturing GMP |
| 2020 | Sports care activity for Taitung Red Leaves |
| 2020 | “Celludoxa Sanovazo trauma dressing”, second-level medical device inspection and registration approval, medical equipment license issued by the Ministry of Health and Welfare |
| 2020 | CSTC 1clinical phase II trial results unblinded, 12 weeks of treatment for patients with wounds reduced by 90% |
| 2019 | TFDA Medical Device Manufacturing GMP |
| 2019 | ISO13485 International Medical Equipment Manufacturing GMP |
| 2019 | U.S. FDA Phase II dementia clinical results unblinded and identified drug characteristics and responding drug groups. After 12 weeks of treatment, the intelligent analysis has improved by more than 2 points, and the number of people who have improved at the same time is 80%. Established a trial plan for Phase III clinical trials and improved the success rate. It is the world's first new drug for external use of dementia. |
| 2019 | Visited by teachers and students of the Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University |
| 2019 | Visited by Department of Biotechnology, Tainan University |
| 2019 | Visited by the Department of Medical Science Industries, Chang Jung Christian University |
| 2019 | Visited by Institute of Translational Medicine and New Drug Development, China Medical University |
| 2018 | Visited by teachers and students of Guoguang Laboratory School, National Sun Yat-sen University |
| 2018 | Visited by teachers and students of Graduate Institute of Clinical Medicine, Kaohsiung Medical University |
| 2018 | Signed a memorandum of cooperation for medical equipment experience with National Cheng Kung University Hospital |
| 2018 | Sports care activity for the basketball team of Shin Rong Senior High School |
| 2018 | Sports care activity for the eSports team of Far East University |
| 2018 | Sports care activity for baseball team of Taitung Fengtian Elementary School |
| 2017 | Clinical trial results of head and neck cancer radiotherapy pain relief new drug ACA have been completed. The results show that 90% of patients are protected from radiotherapy skin damage and skin pain. |
| 2017 | The phase II clinical trial of BAC drug for Alzheimer's disease and vascular dementia has begun to enroll cases in eight trial centers in the United States. |
| 2017 | Walking activity on Tainan National Disaster Prevention Day |
| 2017 | Charsire Biotechnology Corp. was awarded the Ministry of Finance's 2017 Outstanding Invoice Business Award |
| 2017 | Charsire joined Tainan Science Park activity for health theme |
| 2016 | Charsire joined hands with the National Taiwan Sport University to show the determination of industry-academia cooperation, and hope to set up an industry-academia new model for Taiwan's sports industry, and provide products for cooperative R&D and testing. Charsire also provided injury care sponsorship for athletes. |
| 2015 | Charsire was selected as the 2015 Deloitte Technology Fast 500 Asia Pacific, Fast 500 |
| 2015 | Charsire's love and care activities: collecting second-hand clothes for donation |
| 2015 | ACA, a new pain relief drug for head and neck cancer radiotherapy, has been approved by the Ministry of Health and Welfare for phase I of human clinical trials |
| 2014 | Charsire's love and care activities: love you for life |
| 2013 | Charsire was the 2013 Tainan City Demonstration Workplace of "Cherish Life and LOHAS Workplace", promoting the importance of workplace mental health. Mayor William Lai personally issued the “Cherish Life and LOHAS Workplace” certification mark and certificate of appreciation. |
| 2013 | U.S. FDA approves the phase II of human clinical trial, a new drug for diabetic ulcer wounds, CSTC1 |
| 2013 | Completed the construction of the pharmaceutical factory CDMO |
| 2010 | Established an experimental research and development center for valuable instruments, and established the latest testing and research and development instruments: HPLC/GC/MS/MS, LC/MS/MS, AA and other |
| |
